Initial Public Offering (IPO) News: Breaking Initial Public Offering (IPO) News, Comments and Articles. - Page: 5

Human medicines European Public Assessment Report (EPAR): Epivir, lamivudine, Revision: 27, Authorised

Many public pools contaminated with human waste, CDC says

(HealthDay)—There are few things more inviting than a cool, clear pool on a hot summer day. But a new federal report will have you thinking twice before dipping a toe in the water.

Pennsylvania Departments of Public Welfare, State Ease Transition for New Behavior Specialist License Requirement

HARRISBURG, Pa., May 16, 2013 /PRNewswire-USNewswire/ -- A 2008 law will soon require staff serving children with autism spectrum disorders to hold a Behavior Specialist license in order to continue billing the Medical Assistance program for services. To help service providers meet this requirement, the Pennsylvania Departments of Public Welfare (DPW) and State (DOS) have announced a plan to hel...

CDC Study Finds Fecal Contamination in Pools

A study of public pools conducted during last summer’s swim season found that feces are frequently introduced into pool water by swimmers. Through the study, released today by the Centers for Disease Control and Prevention (CDC), researchers found germs in samples of pool filter water collected from public pools. The CDC collected samples of water

Human medicines European Public Assessment Report (EPAR): Glustin, pioglitazone, Revision: 20, Authorised

Human medicines European Public Assessment Report (EPAR): Glubrava, pioglitazone / metformin, Revision: 10, Authorised

Human medicines European Public Assessment Report (EPAR): Actos, pioglitazone, Revision: 20, Authorised

The How's and Why's of Infection Prevention Principles in the GI/Endoscopy Unit

The risk of infection should never be cause for concern, and—as healthcare professionals – we must maintain the public trust by providing safe, high-quality care through evidence-based infection prevention standards, processes and practice. Human error can be mitigated through education, ongoing training and meticulous attention to reprocessing

Veterinary medicine European Public Assessment Report (EPAR): RevitaCAM, meloxicam, Revision: 2, Authorised

Many mental-illness websites show drug-company bias, study finds

Although mental-health-related websites are generally biased in favor of a biological explanation of mental illness and drug treatments, those owned or funded by pharmaceutical companies tend to be more biased than others and, thus, “cannot be considered an objective source of mental health information for the public or practitioners,” according to a study published this month in the journal A...

Ambit Slices Price of IPO, Increases Number of Shares Offered

San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering. Shares of the biopharmaceutical company began trad...

Human medicines European Public Assessment Report (EPAR): Grepid, clopidogrel, Revision: 8, Authorised

HHS announces actions to improve safety and quality of child care

Helping to answer President Obama’s call to ensure quality early education for every American child, the U.S. Department of Health and Human Services (HHS) proposed today a new regulation for public comment that will better ensure children’s health and safety in child care and promote school readiness. Under the proposed rule, states, territories and t...

Stem Cell Action Coalition Applauds Cloned Stem Cell Breakthrough

The Stem Cell Action Coalition, a network of 75 nonprofit disease advocacy groups, scientific societies and academic centers, applauds the researchers at the Oregon Health and Science University for their groundbreaking accomplishment of producing stem cells utilizing the process of somatic cell nuclear transfer (SCNT). “The creation of c...

Human medicines European Public Assessment Report (EPAR): Kivexa, abacavir / lamivudine, Revision: 16, Authorised

Act Now to Protect Public Health and Prepare for the Upcoming Flu Season

As many as 49,000 people die from the flu annually, depending on the season, and children and the elderly are the most vulnerable. Among the 138 children who died from the flu during the 2012-2013 season, the Centers for Disease Control and Preventio...

PerkinElmer Launches New OneSource® Laboratory Consulting Services to Drive Improved Laboratory Efficiencies

New consulting services will leverage expertise derived from the largest laboratory services and informatics offering install base PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it is expanding its OneSource®

ConnectedHealth Expands Team with Senior Operational and Retail Strategist– Company Growing Quickly in Evolving Marketplace

ConnectedHealth, provider of a revolutionary health insurance exchange and decision-support platform for employers, health plans and consumers, is proud to announce and welcome David Shevock as its new Senior Vice President. Shevock will play a vital role, leading the development and operational teams that define the vision, technical architecture and road...

BIO Praises House of Representatives for Passing H.R. 701

H.R. 701 sets a deadline to complete rulemaking on Regulation A reforms The Biotechnology Industry Organization (BIO) today lauds the House of Representatives for passing H.R. 701, a bill to speed the implementation of a key capital formation provision in the Jumpstart Our Business Startups (JOBS) Act. H.R. 701 was introduced by Rep. Patrick McHenry...

ALPCO to Exhibit with BÜHLMANN Laboratories at DDW 2013 and Feature Fecal Calprotectin ELISA

Salem, NH, May 16, 2013 --(PR.com)-- ALPCO Diagnostics and BÜHLMANN Laboratories AG will be exhibiting together at Digestive Disease Week in Orlando, FL May 19-21, 2013. The partnering companies will feature BÜHLMANN’s Fecal Calprotectin ELISA at the meeting. The test is pending FDA clearance for In Vitro Diagnostic use in the United States. An FDA cleared Fecal Calprotectin test...

Human medicines European Public Assessment Report (EPAR): Trizivir, abacavir (as sulfate) / lamivudine / zidovudine, Revision: 20, Authorised

The Brain Aneurysm Foundation Heads to Capitol Hill on May 21, 2013 for National Lobbying Effort

Organization and Supporters to Encourage Legislators to Support Funding for Brain Aneurysm Research and the Importance of Early Detection Screening. Hanover, MA (PRWEB) May 16, 2013 According to the Brain Aneurysm Foundation, it is estimated that more than 6 million people in the United States have an unruptured brain aneurysm. Although all aneurysms do not rupture during the course of a person�...

TigerText and AirWatch Partner to Offer Comprehensive Mobile Security Solution for Healthcare

Device management and secure messaging solution has been selected by Community Hospice of Texas TigerText, the leader in secure, real-time messaging for health care and enterprise and AirWatch, the global leader and innovator in mobile device security and the largest Enterprise Mobility Management (EMM) provider, today announced a partner...

Introduce standard cigarette packets now

Public health experts were disappointed and surprised not to see legislation to introduce standard packaging for cigarettes included in the Queen’s speech. The idea behind standard packaging is...

Mylan’s Autor-de-Force Move into Quality “Differentiation” and Sterile Injectables

Mylan is investing heavily to create a competitive advantage based on manufacturing quality – and public policy. The firm’s recruitment of FDA’s Deborah Autor highlights a strategy to spend more on quality while aiming at higher margins, especi...